Browsing by Author Karakas, Hilal

Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)
2025Impact of First-Line Tyrosine Kinase Inhibitor Selection on Survival Outcomes With Second-Line Nivolumab in Metastatic Renal Cell CarcinomaKuzu, Omer Faruk; Bolek, Hatice; Camoz, Elif Sertesen; Karakas, Hilal; Sekmek, Serhat; Sim, Saadet; Urun, Yuksel
2025The Impact of Smoking on Nivolumab Outcomes in Renal Cell Carcinoma: Real-World Data From the Turkish Oncology Group Kidney Cancer ConsortiumCamoz, Elif Sertesen; Bolek, Hatice; Kuzu, Omer Faruk; Sim, Saadet; Karakas, Hilal; Sekmek, Serhat; Urun, Yuksel
2025Uric Acid Level in Metastatic Renal Cell Carcinoma Treated With Nivolumab: a Turkish Oncology Group Kidney Cancer Consortium (TKCC) StudySekmek, Serhat; Bolek, Hatice; Kuzu, Omer Faruk; Camoz, Elif Sertesen; Sim, Saadet; Karakas, Hilal; Urun, Yuksel
2025Yeni Teşhis Konulan Multipl Sklerozlu Bireylerde Servikal Omurilik Lezyonunun Üst Ekstremite Fonksiyonu Üzerindeki Etkisinin DeğerlendirilmesiCinar, Bilge Piri; Ozakbas, Serkan ; Kaya, Ergi; Baba, Cavid; Özdoğar, Asiye Tuba; Yapıcı, Nurbanu Aygündüz; Karakas, Hilal